CVI Holdings LLC purchased a new position in shares of Heat Biologics Inc (NASDAQ:HTBX) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,557,768 shares of the biopharmaceutical company’s stock, valued at approximately $1,527,000. Heat Biologics comprises 3.4% of CVI Holdings LLC’s portfolio, making the stock its 6th biggest position. CVI Holdings LLC owned about 6.70% of Heat Biologics at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of HTBX. Northern Trust Corp purchased a new position in shares of Heat Biologics during the second quarter valued at approximately $111,000. Vanguard Group Inc. lifted its holdings in shares of Heat Biologics by 20.6% during the third quarter. Vanguard Group Inc. now owns 798,561 shares of the biopharmaceutical company’s stock valued at $1,597,000 after purchasing an additional 136,256 shares during the last quarter. Vanguard Group Inc lifted its holdings in shares of Heat Biologics by 20.6% during the third quarter. Vanguard Group Inc now owns 798,561 shares of the biopharmaceutical company’s stock valued at $1,597,000 after purchasing an additional 136,256 shares during the last quarter. Finally, Virtu Financial LLC purchased a new position in shares of Heat Biologics during the fourth quarter valued at approximately $55,000. Hedge funds and other institutional investors own 16.39% of the company’s stock.
Separately, ValuEngine lowered shares of Heat Biologics from a “buy” rating to a “hold” rating in a report on Tuesday, December 25th.
Shares of NASDAQ HTBX opened at $1.24 on Friday. Heat Biologics Inc has a twelve month low of $0.95 and a twelve month high of $4.30.
TRADEMARK VIOLATION WARNING: “CVI Holdings LLC Purchases Shares of 1,557,768 Heat Biologics Inc (HTBX)” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2019/03/17/cvi-holdings-llc-purchases-shares-of-1557768-heat-biologics-inc-htbx.html.
Heat Biologics Profile
Heat Biologics, Inc, a biopharmaceutical company, focuses on developing approaches to activate and co-stimulate a patient's immune system against cancer in the United States. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors hot and be administered in combination with checkpoint inhibitors and other immuno-modulators to enhance clinical effectiveness.
Recommended Story: Cost of Capital Explained
Want to see what other hedge funds are holding HTBX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heat Biologics Inc (NASDAQ:HTBX).
Receive News & Ratings for Heat Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heat Biologics and related companies with MarketBeat.com's FREE daily email newsletter.